Today: 21 May 2026
Morgan Stanley stock climbs after earnings beat — deal pipeline and Fed are the next tests
16 January 2026
1 min read

Morgan Stanley stock climbs after earnings beat — deal pipeline and Fed are the next tests

New York, Jan 16, 2026, 12:55 EST — Regular session

Morgan Stanley shares edged up roughly 0.6%, hitting $192.40 by midday Friday. The stock traded between $190.39 and $192.69 after kicking off at $190.76.

The gain follows Thursday’s earnings, when the Wall Street bank topped profit forecasts as investment banking revenue surged 47% to $2.41 billion, fueled by debt underwriting and a rebound in M&A activity. The bank posted $2.68 per share for the quarter, outpacing the $2.44 consensus from LSEG. CFO Sharon Yeshaya told Reuters she’s seeing “an accelerating pipeline in M&A and IPOs.” CEO Ted Pick said on the earnings call the bank plans to “continue to be patient” on acquisitions amid what he called a “complicated” environment. Reuters

Morgan Stanley offers a sharp lens on U.S. dealmaking and market moves thanks to its institutional securities arm, which anchors underwriting and advisory work. Investors are betting that the pickup in issuance seen last year will extend into 2026. They’re also counting on wealth inflows and trading to support the market when volatility kicks in.

Morgan Stanley’s latest SEC filing shows fourth-quarter net revenue hitting $17.89 billion, with net income at $4.40 billion. Its return on tangible common equity (ROTCE) came in at 21.8%, excluding goodwill and intangibles. Wealth Management revenue climbed to $8.43 billion as the firm added $122.3 billion in net new assets during the quarter. The bank’s standardized common equity tier 1 (CET1) capital ratio was 15.0% at year-end. Morgan Stanley repurchased $1.5 billion of shares and announced a $1.00 quarterly dividend, payable Feb. 13 to shareholders of record Jan. 30.

Bank execs are already eyeing a busier 2026 after underwriting and advisory fees picked up last year. According to Dealogic, global investment banking revenue topped $100 billion in 2025. Macrae Sykes, portfolio manager at Gabelli Funds, said: “I expect 2026 to be a very strong year of IPO issuance and announced M&A.” For clarity, IPOs are stock market debuts. Reuters

A Reuters Breakingviews column pointed out that Morgan Stanley and Goldman Sachs are now trading at price-to-book multiples above their pre-crisis highs — roughly 3.1 times and 2.7 times projected book value, respectively. Yet, both banks are generating lower returns on equity compared to 2007, a gap that could weigh on these expensive stocks if growth slows.

The next phase hinges on markets playing along. A drop in equity prices or a sudden dip in volatility could prompt companies to put offerings on hold and sponsors to pause buyouts, which would blunt fee growth.

Traders are zeroing in on the Federal Reserve’s policy meeting set for Jan. 27-28, a key moment for rate forecasts that directly influence issuance and risk appetite. Morgan Stanley investors will be keen to see if new mandates lead to announced deals and follow-on offerings early in Q1.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Costco stock price dips as dividend lands; investors wait on sales and earnings
Previous Story

Costco stock price dips as dividend lands; investors wait on sales and earnings

CrowdStrike stock price today: CRWD steadies after China ban report and outage lawsuit dismissal
Next Story

CrowdStrike stock price today: CRWD steadies after China ban report and outage lawsuit dismissal

Go toTop